Segment Information (Tables)

3 Months Ended

Mar. 28, 2020

Schedule of Segment Reportable Segments, by Segment

The following tables set forth certain information relating to our segments’ operations:



(amounts in thousands)	North America			Europe			Australasia			Total Operating Segments			Corporate and Unallocated Costs			Total Consolidated
Three Months Ended March 28, 2020
Total net revenues	$	587,048		$	281,807		$	112,972		$	981,827		$	—		$	981,827
Intersegment net revenues	(312		)	(314		)	(2,014		)	(2,640		)	—			(2,640		)
Net revenues from external customers	$	586,736		$	281,493		$	110,958		$	979,187		$	—		$	979,187
Impairment and restructuring charges	943			2,001			264			3,208			3,337			6,545
Adjusted EBITDA	48,990			23,326			8,725			81,041			(6,533		)	74,508
Three Months Ended March 30, 2019
Total net revenues	$	565,701		$	299,993		$	146,520		$	1,012,214		$	—		$	1,012,214
Intersegment net revenues	(596		)	(27		)	(1,331		)	(1,954		)	—			(1,954		)
Net revenues from external customers	$	565,105		$	299,966		$	145,189		$	1,010,260		$	—		$	1,010,260
Impairment and restructuring charges	1,958			1,309			465			3,732			(13		)	3,719
Adjusted EBITDA	52,796			27,638			16,380			96,814			(7,536		)	89,278

Reconciliation of Net Income to Adjusted EBITDA

Reconciliations of net income (loss) to Adjusted EBITDA are as follows:



	Three Months Ended
(amounts in thousands)	March 28, 2020			March 30, 2019
Net income (loss)	$	(230	)	$	15,777
Income tax expense	1,197			10,349
Depreciation and amortization	33,446			30,898
Interest expense, net	16,604			17,656
Impairment and restructuring charges⁽¹⁾	6,695			4,103
(Gain) loss on sale of property and equipment	(2,073		)	512
Share-based compensation expense	3,733			2,596
Non-cash foreign exchange transaction/translation (income) loss	(1,189		)	(3,686		)
Other items⁽²⁾	16,325			10,408
Other non-cash items	—			665
Adjusted EBITDA	$	74,508		$	89,278

(1)

Impairment and restructuring charges consist of (i) impairment and restructuring charges that are included in our consolidated unaudited statements of operations plus (ii) additional charges relating to inventory and/or manufacturing of our products that are included in cost of sales in the accompanying unaudited consolidated statements of operations in the amount of $150 and $384 for the three months ended March 28, 2020 and March 30, 2019, respectively. For further explanation of impairment and restructuring charges that are included in our consolidated statements of operations, see Note 17 - Impairment and Restructuring Charges in our financial statements.

(2)

Other non-recurring items not core to ongoing business activity include: (i) in the three months ended March 28, 2020 (1) $11,706 in legal costs and professional expenses relating primarily to litigation, (2) $3,110 in facility closure and consolidation costs related to our facility footprint rationalization program, and (3) $1,235 in one-time lease termination charges; and (ii) in the three months ended March 30, 2019, (1) $4,827 in facility closure and consolidation costs related to our facility footprint rationalization program, (2) $2,934 in acquisition and integration costs, and (3) $1,648 in legal costs and professional expenses relating primarily to litigation.

The prior period information has been revised and reclassified to conform with current period presentation. Please refer to Note 25 - Revision of Prior Period Financial Statements.